North America Extracellular Matrix Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Raw Material (Bovine, Porcine, and Other Raw Material), Application (Soft Tissue Repair, Dural Repair, Wound Healing, Cardiac Repair, Pericardial Repair, and Vascular Repair and Reconstruction)
Market Introduction
A large network of proteins and other molecules that surround, support, and give structure to cells and tissues in the body. The extracellular matrix helps cells attach to, and communicate with, nearby cells, and plays an important role in cell growth, cell movement, and other cell functions. The extracellular matrix is also involved in repairing damaged tissue. Abnormal changes in the extracellular matrix may lead to the development of certain diseases, such as cancer.
Moreover, increasing incidences of trauma and cardiovascular diseases and increasing vascular reconstruction procedures. However, challenges during the usage of decellularized extracellular matrix are expected to restrict the market growth during the forecast period.
The US-registered highest number of deaths due to the COVID-19 pandemic. The chaotic situation was created in the medical industry across the countries, increased demand for diagnosing and therapeutic devices have dramatically increased in the hospitals. For instance, the demand for ventilators, respirators, and in vitro diagnostic (IVD) tests has risen drastically in hospitals across the countries in the region. The FDA has increased its efforts to support the health of people and has imposed several guidelines and for hospitals and medical device companies. Various companies also enhanced their research and development activities for diagnostics tests and therapeutic devices. Although the healthcare sector had witnessed SARS, H1N1, and other outbreaks in the last few years, the severity of the COVID-19 has made the situation more complicated due to its mode of transmission. North America has been witnessing a growing number of COVID-19 cases since its outbreak.
Get more information on this report : 
Market Overview and Dynamics
The North America extracellular matrix market is expected to reach US$ 20,111.6 Thousands by 2028 from US$ 12,163.1 Thousands in 2021. The market is estimated to grow at a CAGR of 7.4% from 2021–2028. Developing nations are significantly improving their healthcare facilities and services and are heading toward technological advancements. With increasing manufacturing costs against their practices, medical device manufacturers are struggling to generate enough revenue to please their investors. These economies are conducting enormous conferences and research activities for the extracellular matrix. The emerging markets in developing economies are expected to offer better and lucrative growth opportunities for leading players to expand their business and geographic reach. Several emerging nations are spending heavily on the development biotechnology sector of the healthcare industry. The market is consolidating with several local and multinational players engaged in R&D for various technologies in the biotechnology sectors. Thus, the market is likely to show significant growth opportunities during the forecast period due to the factors mentioned above.
Key Market Segments
In terms of raw material, the porcine segment accounted for the largest share of the North America extracellular matrix market in 2020. In terms of application, the soft tissue repair segment accounted for the largest share of the North America extracellular matrix market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the extracellular matrix market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Medtronic, Merck Kgaa, Mtf Biologics, Smith & Nephew, Anteris, Aziyo, Coloplast Group, Baxter, DSM, and Cook Biotech.
Reasons to Buy Report
- To understand the North America extracellular matrix market landscape and identify market segments that are likely to guarantee a strong return
- To comprehend the ever-changing market landscape and stay ahead in competition
- To efficiently plan merger and acquisition, and partnership deals in the North America extracellular matrix market by identifying segments with the most promising probable sales
- To make knowledgeable business decisions from perceptive and comprehensive analysis of the market performance of various segments
- To obtain market revenue forecast of the North America extracellular matrix market based on various segments for the period 2021–2028
NORTH AMERICA EXTRACELLULAR MATRIX MARKET SEGMENTATION
By Raw Material
- Bovine
- Porcine
- Others
By Application
- Soft Tissue Repair
- Dural Repair
- Wound Healing
- Cardiac Repair
- Pericardial Repair
- Vascular Repair and Reconstruction
By Country
- North America
- US
- Canada
- Mexico
Companies Mentioned
- Medtronic
- Merck Kgaa
- Mtf Biologics
- Smith & Nephew
- Anteris
- Aziyo
- Coloplast Group
- Baxter
- DSM
- Cook Biotech
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Extracellular Matrix Market – By Raw Material
1.3.2 North America Extracellular Matrix Market – By Application
1.3.3 North America Extracellular Matrix Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Extracellular Matrix Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Experts Opinion
5. Extracellular Matrix Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Significantly Rising Incidences of Trauma & Cardiovascular Diseases
5.1.2 Increasing Vascular Reconstruction Procedures
5.2 Market Restraints
5.2.1 Challenges During the Usage of Decellularized Extracellular Matrix
5.3 Market Opportunities
5.3.1 Growth Opportunities in the Developing Nations
5.4 Future Trends
5.4.1 Benefits of Treating Cancer
5.5 Impact Analysis
6. Extracellular Matrix Market– North America Analysis
6.1 North America Extracellular Matrix Market Revenue Forecast and Analysis
7. Extracellular Matrix Market Revenue and Forecasts To 2028 – Raw Material
7.1 Overview
7.2 North America Extracellular Matrix Market Share by Raw Material - 2020 & 2028 (%)
7.3 Porcine
7.3.1 Overview
7.3.2 Porcine: Extracellular Matrix Market Revenue and Forecast to 2028 (US$ Thousand)
7.4 Bovine
7.4.1 Overview
7.4.2 Bovine: Extracellular Matrix Market Revenue and Forecast to 2028 (US$ Thousand)
7.5 Others
7.5.1 Overview
7.5.2 Others: Extracellular Matrix Market Revenue and Forecast to 2028 (US$ Thousand)
8. Extracellular Matrix Market Analysis – By Application
8.1 Overview
8.2 North America Extracellular Matrix Market, By Application, 2020 & 2028 (%)
8.3 Soft Tissue Repair
8.3.1 Overview
8.3.2 Soft Tissue Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
8.4 Dural Repair
8.4.1 Overview
8.4.2 Dural Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
8.5 Wound Healing
8.5.1 Overview
8.5.2 Wound Healing: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
8.6 Cardiac Repair
8.6.1 Overview
8.6.2 Cardiac Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
8.7 Pericardial Repair
8.7.1 Overview
8.7.2 Pericardial Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
8.8 Vascular Repair and Reconstruction
8.8.1 Overview
8.8.2 Vascular Repair and Reconstruction: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
9. North America Extracellular Matrix Market – Geographic Analysis
9.1 North America: Extracellular Matrix Market
9.1.1 Overview
9.1.2 North America: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.3 North America: Extracellular Matrix Market, by Raw Material, 2019–2028 (US$ Thousand)
9.1.4 North America: Extracellular Matrix Market, by Application, 2019–2028 (US$ Thousand)
9.1.5 North America: Extracellular Matrix Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.1.1 US: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.1.2 US: Extracellular Matrix Market, by Raw Material, 2019–2028 (US$ Thousand)
9.1.5.1.3 US: Extracellular Matrix Market, by Application, 2019–2028 (US$ Thousand)
9.1.5.2 Canada: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.2.1 Canada: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.2.2 Canada: Extracellular Matrix Market, by Raw Material, 2019–2028 (US$ Thousand)
9.1.5.2.3 Canada: Extracellular Matrix Market, by Application, 2019–2028 (US$ Thousand)
9.1.5.3 Mexico: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.3.1 Mexico: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.3.2 Mexico: Extracellular Matrix Market, by Raw Material, 2019–2028 (US$ Thousand)
9.1.5.3.3 Mexico: Extracellular Matrix Market, by Application, 2019–2028 (US$ Thousand)
10. Impact of COVID-19 Pandemic on North America Extracellular Matrix Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Extracellular Matrix Market
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Medtronic
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 MERCK KGaA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 MTF Biologics
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Smith & Nephew
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Anteris
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Aziyo
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Coloplast Group
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Baxter
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 DSM
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Cook Biotech Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 2. North America Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 3. US: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 4. US Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 5. Canada Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 6. Canada: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 7. Mexico Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 8. Mexico: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 9. Organic Developments Done By Companies
Table 10. Inorganic Developments Done By Companies
Table 11. Glossary of Terms, Extracellular Matrix Market
LIST OF FIGURES
Figure 1. Extracellular Matrix Market Segmentation
Figure 2. North America Extracellular Matrix Market Overview
Figure 3. Porcine Segment Held Largest Share by Raw Material Segment in Extracellular Matrix Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Extracellular Matrix Market, Industry Landscape
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis of Drivers and Restraints Pertaining to Extracellular Matrix Market
Figure 9. North America Extracellular Matrix Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10. North America Extracellular Matrix Market Share by Raw Material - 2020 & 2028 (%)
Figure 11. Porcine: Extracellular Matrix Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 12. Bovine: Extracellular Matrix Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 13. Others: Extracellular Matrix Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 14. North America Extracellular Matrix Market, By Application, 2020 & 2028 (%)
Figure 15. Soft Tissue Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 16. Dural Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 17. Wound Healing: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 18. Cardiac Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 19. Pericardial Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 20. Vascular Repair and Reconstruction: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 21. North America: Extracellular Matrix Market, by Key Country – Revenue (2021) (US$ Thousand)
Figure 22. North America Extracellular Matrix Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 23. North America: Extracellular Matrix Market, by Country, 2021 & 2028 (%)
Figure 24. US: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 25. Canada: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. Mexico: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. Impact of COVID-19 Pandemic in North American Country Markets
Figure 28. Growth Strategies in the Extracellular Matrix Market
- Medtronic
- Merck Kgaa
- Mtf Biologics
- Smith & Nephew
- Anteris
- Aziyo
- Coloplast Group
- Baxter
- DSM
- Cook Biotech
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America extracellular matrix market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America extracellular matrix market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.